AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

CollPlant Biotechnologies... (CLGN)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

3.48

-0.07 (-1.97%)

At close: Feb 20, 2025, 3:19 PM

3.48

0.00%

After-hours: Feb 20, 2025, 03:19 PM EST

undefined% (undefined)

Bid	3.21
Market Cap	39.83M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-1.53
PE Ratio (ttm)	-2.27
Forward PE	n/a
Analyst	Buy

Ask	3.5
Volume	5,560
Avg. Volume (20D)	10,274
Open	3.50
Previous Close	3.55
Day's Range	3.48 - 3.54
52-Week Range	3.24 - 6.75
Beta	undefined

About CLGN

CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3D printing of tissues and organs; dermal filler and...

[Show more]

Industry Biotechnology

Sector Healthcare

IPO Date Jan 31, 2018

Employees 75

Stock Exchange NASDAQ

Ticker Symbol CLGN

Website https://www.collplant.com

Full Company Profile

Analyst Forecast

According to 3 analyst ratings, the average rating for CLGN stock is "Buy." The 12-month stock price forecast is $14, which is an increase of 302.59% from the latest price.

Buy 66.67%

Hold 0.00%

Sell 0.00%

Stock Forecasts

Next Earnings Release

CollPlant Biotechnologies Ltd. is scheduled to release its earnings on Apr 3, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

2 months ago

-0.23%

CollPlant Biotechnologies shares are trading lower... Unlock content with Pro Subscription

News

2 months ago · seekingalpha.com

CollPlant Biotechnologies Ltd (CLGN) Q3 2024 Earnings Call Transcript

CollPlant Biotechnologies Ltd (NASDAQ:CLGN ) Q3 2024 Earnings Conference Call November 27, 2024 10:00 AM ET Company Participants Dory Kurowski - LifeSci Advisors Yehiel Tal - CEO Eran Rotem - Deputy C...